Clinical director

Colin Kerr

Published: Saturday, February 1, 2020

Heidelberg Engineering has appointed Christopher Mody as its Clinical Director. In this new role, Dr Mody, an ophthalmic scientist with 30 years’ clinical ophthalmology experience in the public sector and seven years at Heidelberg Engineering UK, will be facilitating the exchange of scientific information between the global ophthalmic community and the company. “Chris Mody is ideally suited to support our translational science program designed to deliver comprehensive, clinically relevant solutions to our customers. His knowledge will continue to strengthen our research alliances, while his passion for education will enhance the company’s role in advancing patient care.”, said Ali Tafreshi, Head of Product Management and Clinical Affairs at Heidelberg Engineering. www.heidelbergengineering.com/int/company

Latest Articles

Thinking Beyond Optics: Diversity, Equity, and Inclusion (DEI) and Unconscious Bias in Ophthalmology

Beyond Sight: A Clearer Vision for Equity in Ophthalmology

Refractions of Bias: Seeing DEI Clearly in Ophthalmology

Happy Patients, Higher Volumes

Digitalisation reduces errors and saves time, making a surgeon’s life easier.

Addressing Postoperative Visual Complications

Managing aberrations after laser refractive surgery requires a multi-layered approach.

3D Printing Helps Transform Ukrainian Eye Care

The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.

Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation

Emerging Microbial Trends That Could Affect Your Practices

A triptych of challenges paints a concerning picture for ophthalmologists across the globe.

Improving Outcomes with Laser-Assisted Surgery

Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.

Could the Corneal Transplant Pool Increase?

Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.